| Broad consent for research with biological samples: workshop conclusions C Grady, L Eckstein, B Berkman, D Brock, R Cook-Deegan, SM Fullerton, ... The American Journal of Bioethics 15 (9), 34-42, 2015 | 291 | 2015 |
| A framework for analyzing the ethics of disclosing genetic research findings L Eckstein, JR Garrett, BE Berkman Journal of Law, Medicine & Ethics 42 (2), 190-207, 2014 | 63 | 2014 |
| The unintended implications of blurring the line between research and clinical care in a genomic age BE Berkman, SC Hull, L Eckstein Personalized Medicine 11 (3), 285-295, 2014 | 56 | 2014 |
| Toward better governance of human genomic data KC O’Doherty, M Shabani, ES Dove, HB Bentzen, P Borry, MM Burgess, ... Nature genetics 53 (1), 2-8, 2021 | 39 | 2021 |
| Key challenges in bringing CRISPR-mediated somatic cell therapy into the clinic D Nicol, L Eckstein, M Morrison, JS Sherkow, M Otlowski, T Whitton, ... Genome medicine 9, 1-4, 2017 | 27 | 2017 |
| Australia: regulating genomic data sharing to promote public trust L Eckstein, D Chalmers, C Critchley, R Jeanneret, R McWhirter, J Nielsen, ... Human Genetics 137, 583-591, 2018 | 23 | 2018 |
| Moving forward on consent practices in Australia RE McWhirter, L Eckstein Journal of Bioethical Inquiry 15, 243-257, 2018 | 13 | 2018 |
| Building a more connected DSMB: better integrating ethics review and safety monitoring L Eckstein Accountability in research 22 (2), 81-105, 2015 | 13 | 2015 |
| Consent insufficient for data release D Nicol, L Eckstein, HB Bentzen, P Borry, M Burgess, W Burke, ... Science 364 (6439), 445-446, 2019 | 10 | 2019 |
| The ethics of large-scale genomic research BE Berkman, ZE Shapiro, L Eckstein, ER Pike Ethical Reasoning in Big Data: An Exploratory Analysis, 53-69, 2016 | 10 | 2016 |
| Assessing the legal duty to use or disclose interim data for ongoing clinical trials L Eckstein Journal of Law and the Biosciences 6 (1), 51-84, 2019 | 8 | 2019 |
| Beyond racial and ethnic analyses in clinical research: a proposed model for Institutional Review Boards L Eckstein Food & Drug LJ 66, 243, 2011 | 8 | 2011 |
| Integrating public participation, transparency and accountability into governance of marketing authorisation for genome editing products J Nielsen, L Eckstein, D Nicol, C Stewart Frontiers in Political Science 3, 747838, 2021 | 6 | 2021 |
| A scenario-based methodology for analyzing the ethical, legal, and social issues in genomic data sharing R McWhirter, L Eckstein, D Chalmers, C Critchley, J Nielsen, M Otlowski, ... Journal of Empirical Research on Human Research Ethics 15 (4), 355-364, 2020 | 6 | 2020 |
| Engaging racial and ethnic groups in the regulation of research: lessons from research in emergency settings L Eckstein Hous. J. Health L. & Pol'y 12, 1, 2011 | 6 | 2011 |
| Enhancing early detection of cognitive impairment in the criminal justice system: feasibility of a proposed method R Jeanneret, C Spiranovic, L Eckstein, R McWhirter, A Arstein-Kerslake, ... Current Issues in Criminal Justice 31 (1), 60-74, 2019 | 5 | 2019 |
| Strategies to guide the return of genomic research findings: an Australian perspective L Eckstein, M Otlowski Journal of Bioethical Inquiry 15, 403-415, 2018 | 5 | 2018 |
| Criteria for Decision-Making Capacity: Between Understanding and Evidencing a Choice. SYH Kim Journal of law and Medicine 24 (3), 678-694, 2017 | 5 | 2017 |
| Gene Editing Clinical Trials Could Slip through Australian Regulatory Cracks. D Nicol, L Eckstein Journal of law and Medicine 27 (2), 274-283, 2019 | 4 | 2019 |
| Regulatory Challenges of Synthetic Biology Trials and Other Highly Innovation Investigational Products L Eckstein Macquarie LJ 15, 65, 2015 | 4 | 2015 |
